SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-375645
Filing Date
2014-10-20
Accepted
2014-10-20 08:02:11
Documents
8
Period of Report
2014-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d806711d8k.htm 8-K 41923
2 EX-4.1 d806711dex41.htm EX-4.1 74480
3 EX-4.2 d806711dex42.htm EX-4.2 68475
4 EX-10.1 d806711dex101.htm EX-10.1 386563
5 EX-10.2 d806711dex102.htm EX-10.2 24237
6 EX-10.3 d806711dex103.htm EX-10.3 445199
7 EX-99.1 d806711dex991.htm EX-99.1 20019
8 GRAPHIC g806711g43x64.jpg GRAPHIC 4104
  Complete submission text file 0001193125-14-375645.txt   1068232
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 141163047
SIC: 2834 Pharmaceutical Preparations